These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 9871729
1. Synthesis and anti-inflammatory activity of chalcone derivatives. Herencia F, Ferrándiz ML, Ubeda A, Domínguez JN, Charris JE, Lobo GM, Alcaraz MJ. Bioorg Med Chem Lett; 1998 May 19; 8(10):1169-74. PubMed ID: 9871729 [Abstract] [Full Text] [Related]
2. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Shrivastava SK, Srivastava P, Bandresh R, Tripathi PN, Tripathi A. Bioorg Med Chem; 2017 Aug 15; 25(16):4424-4432. PubMed ID: 28669741 [Abstract] [Full Text] [Related]
3. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase. Araico A, Terencio MC, Alcaraz MJ, Domínguez JN, León C, Ferrándiz ML. Life Sci; 2006 May 15; 78(25):2911-8. PubMed ID: 16360707 [Abstract] [Full Text] [Related]
4. Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines. Jantan I, Bukhari SN, Adekoya OA, Sylte I. Drug Des Devel Ther; 2014 May 15; 8():1405-18. PubMed ID: 25258510 [Abstract] [Full Text] [Related]
5. A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase. Rioja I, Terencio MC, Ubeda A, Molina P, Tárraga A, Gonzalez-Tejero A, Alcaraz MJ. Eur J Pharmacol; 2002 Jan 11; 434(3):177-85. PubMed ID: 11779581 [Abstract] [Full Text] [Related]
6. 4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors. Hashimoto H, Maeda K, Ozawa K, Haruta J, Wakitani K. Bioorg Med Chem Lett; 2002 Jan 07; 12(1):65-8. PubMed ID: 11738574 [Abstract] [Full Text] [Related]
7. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system. Santagati A, Granata G, Marrazzo A, Santagati M. Arch Pharm (Weinheim); 2003 Sep 07; 336(9):429-35. PubMed ID: 14528491 [Abstract] [Full Text] [Related]
8. Chromones: A Promising Ring System for New Anti-inflammatory Drugs. Silva CF, Pinto DC, Silva AM. ChemMedChem; 2016 Oct 19; 11(20):2252-2260. PubMed ID: 27630077 [Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase. Shabaan MA, Kamal AM, Faggal SI, Elsahar AE, Mohamed KO. Arch Pharm (Weinheim); 2020 Apr 19; 353(4):e1900308. PubMed ID: 32031284 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors. Cusan C, Spalluto G, Prato M, Adams M, Bodensieck A, Bauer R, Tubaro A, Bernardi P, Da Ros T. Farmaco; 2005 Apr 19; 60(4):327-32. PubMed ID: 15848208 [Abstract] [Full Text] [Related]
11. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study. Abdelgawad MA, Labib MB, Abdel-Latif M. Bioorg Chem; 2017 Oct 19; 74():212-220. PubMed ID: 28865292 [Abstract] [Full Text] [Related]
12. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position. Janusz JM, Young PA, Ridgeway JM, Scherz MW, Enzweiler K, Wu LI, Gan L, Chen J, Kellstein DE, Green SA, Tulich JL, Rosario-Jansen T, Magrisso IJ, Wehmeyer KR, Kuhlenbeck DL, Eichhold TH, Dobson RL. J Med Chem; 1998 Aug 27; 41(18):3515-29. PubMed ID: 9719605 [Abstract] [Full Text] [Related]
13. Building a better aspirin. Pennisi E. Science; 1998 May 22; 280(5367):1191-2. PubMed ID: 9634399 [No Abstract] [Full Text] [Related]
14. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX. Huang Y, Zhang B, Li J, Liu H, Zhang Y, Yang Z, Liu W. Eur J Med Chem; 2019 Oct 15; 180():41-50. PubMed ID: 31299586 [Abstract] [Full Text] [Related]
15. Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways. Tordjman C, Sauveur F, Droual M, Briss S, Andre N, Bellot I, Deschamps C, Wierzbicki M. Arzneimittelforschung; 2003 Oct 15; 53(11):774-9. PubMed ID: 14677373 [Abstract] [Full Text] [Related]
16. 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors. Sogawa S, Nihro Y, Ueda H, Izumi A, Miki T, Matsumoto H, Satoh T. J Med Chem; 1993 Nov 26; 36(24):3904-9. PubMed ID: 8254620 [Abstract] [Full Text] [Related]
17. Amide derivatives of meclofenamic acid as selective cyclooxygenase-2 inhibitors. Kalgutkar AS, Rowlinson SW, Crews BC, Marnett LJ. Bioorg Med Chem Lett; 2002 Feb 25; 12(4):521-4. PubMed ID: 11844663 [Abstract] [Full Text] [Related]
18. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I, Rizk OH, Ibrahim TM, Henen SS, El-Khawass EM, Bayad AE, El-Ashmawy IM, Nematalla HA. Bioorg Chem; 2018 Aug 25; 78():220-235. PubMed ID: 29602046 [Abstract] [Full Text] [Related]
19. Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors. Kolasa T, Brooks CD, Rodriques KE, Summers JB, Dellaria JF, Hulkower KI, Bouska J, Bell RL, Carter GW. J Med Chem; 1997 Feb 28; 40(5):819-24. PubMed ID: 9057869 [Abstract] [Full Text] [Related]
20. Synthesis, DFT calculation, pharmacological evaluation, and catalytic application in the synthesis of diverse pyrano[2,3-c]pyrazole derivatives. Amer MMK, Abdellattif MH, Mouneir SM, Zordok WA, Shehab WS. Bioorg Chem; 2021 Sep 28; 114():105136. PubMed ID: 34328860 [Abstract] [Full Text] [Related] Page: [Next] [New Search]